413. Intravenous and Tablet Formulation of Posaconazole in Antifungal Therapy and Prophylaxis: A Retrospective, Non-Interventional, Multicenter Analysis of Patients Treated in German Tertiary-Care Hospitals

BACKGROUND: Novel formulations (gastro-resistant tablet and intravenous solution) of posaconazole (POS) have been approved in prophylaxis and therapy of invasive fungal diseases (IFDs). The aim of this multicenter noninterventional study was to analyze treatment strategies and clinical effectiveness...

Full description

Saved in:
Bibliographic Details
Published in:Open Forum Infect Dis
Main Authors: Heimann, Sebastian M, Penack, Olaf, Heinz, Werner J, Rachow, Tobias, Egerer, Gerlinde, Kessel, Johanna, Löhnert, Annika, Vehreschild, Janne
Format: Artigo
Language:Inglês
Published: Oxford University Press 2018
Subjects:
Abstracts
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6255490/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy210.424
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items